Table 2.
Sample Characteristics of Matched Analysis Cohort According to Disease Group
| Cancer | COPD | CHF | Neuro | |||||
|---|---|---|---|---|---|---|---|---|
| Trans (n = 37) | Control (n = 111) | Trans (n = 65) | Control (n = 189) | Tran (n = 174) | Control (n = 499) | Trans (n = 92) | Control (n = 276) | |
| Age | 81.9 (7.4) | 82.4 (7.9) | 82.8 (7.7) | 83.4 (8.1) | 87.5 (6.6) | 87.1 (6.4) | 87.0 (5.9) | 87.0 (6.1) |
| White | 26 (70.3) | 81 (73.0) | 53 (81.5) | 150 (80.2) | 136 (78.2) | 393 (78.8) | 64 (69.6) | 191 (69.2) |
| Male | 22 (59.5) | 63 (56.8) | 26 (40) | 76 (40.6) | 77 (44.3) | 218 (43.7) | 35 (38.0) | 91 (33.0) |
| Hospital charges 19–24 months prior to death | 17,121 (36,447) | 17,431 (36,313) | 24,751 (88,782) | 18,381 (48,090) | 29,322 (91,199) | 23,796 (107,924) | 11,623 (32,577) | 9,182 (46,470) |
| Non‐hospital charges 19–24 months prior to death | 25,573 (38,612) | 24,408 (49,121) | 13,184 (16,292) | 11,631 (15,278) | 15,942 (32,949) | 17,240 (47,394) | 7,460 (12,978) | 7,065 (16,270) |
| Days to death | 144.6 | 144.6 | 221.6 | 220.4 | 223.2 | 222.5 | 215.3 | 215.3 |